• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜或手术切除后胃继发病变的危险因素:系统评价和荟萃分析。

Risk factors for gastric metachronous lesions after endoscopic or surgical resection: a systematic review and meta-analysis.

机构信息

Gastroenterology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.

Surgery Department, Centro Hospitalar Lisboa Ocidental, Lisboa, Portugal.

出版信息

Endoscopy. 2022 Sep;54(9):892-901. doi: 10.1055/a-1724-7378. Epub 2022 Feb 1.

DOI:10.1055/a-1724-7378
PMID:35104897
Abstract

INTRODUCTION

Metachronous gastric lesions (MGL) are a significant concern after both endoscopic and surgical resection for early gastric cancer. Identification of risk factors for MGL could help to individualize surveillance schedules and potentially reduce the burden of care, but data are inconclusive. We aimed to identify risk factors for MGL and compare the incidence after endoscopic resection (ER) and subtotal gastrectomy. METHODS : We conducted a systematic review by searching PubMed, ISI, and Scopus, and performed meta-analysis. RESULTS : 52 studies were included. Pooled cumulative MGL incidence after ER was 9.3 % (95 % confidence interval [CI] 7.7 % to 11.0 %), significantly higher than after subtotal gastrectomy (1.2 %, 95 %CI 0.5 % to 2.2 %). After adjusting for mean follow-up, predicted MGL at 5 years was 9.5 % after ER and 0.7 % after subtotal gastrectomy. Older age (mean difference 1.08 years, 95 %CI 0.21 to 1.96), male sex (odds ratio [OR] 1.43, 95 %CI 1.22 to 1.66), family history of gastric cancer (OR 1.88, 95 %CI 1.03 to 3.41), synchronous lesions (OR 1.72, 95 %CI 1.30 to 2.28), severe gastric mucosal atrophy (OR 2.77, 95 %CI 1.22 to 6.29), intestinal metaplasia in corpus (OR 3.15, 95 %CI 1.67 to 5.96), persistent infection (OR 2.08, 95 %CI 1.60 to 2.72), and lower pepsinogen I/II ratio (mean difference -0.54, 95 %CI -0.86 to -0.22) were significantly associated with MGL after ER. Index lesion characteristics were not significantly associated with MGL. ER treatment was possible in 83.2 % of 914 MGLs (95 %CI 72.2 to 91.9 %). CONCLUSION : Follow-up schedules should be different after ER and subtotal gastrectomy, and individualized further based on diverse risk factors.

摘要

介绍

内镜和手术切除早期胃癌后,同时性胃病变(MGL)是一个重要的关注点。确定 MGL 的危险因素有助于个体化监测方案,并可能减轻护理负担,但数据尚无定论。我们旨在确定 MGL 的危险因素,并比较内镜切除(ER)和胃次全切除术后的发病率。

方法

我们通过搜索 PubMed、ISI 和 Scopus 进行了系统综述,并进行了荟萃分析。

结果

共纳入 52 项研究。ER 后累积 MGL 发生率为 9.3%(95%可信区间[CI]7.7%至 11.0%),显著高于胃次全切除术后的 1.2%(95%CI0.5%至 2.2%)。调整平均随访时间后,ER 后 5 年预测的 MGL 发生率为 9.5%,胃次全切除术后为 0.7%。年龄较大(平均差异 1.08 岁,95%CI0.21 至 1.96)、男性(比值比[OR]1.43,95%CI1.22 至 1.66)、胃癌家族史(OR1.88,95%CI1.03 至 3.41)、同时性病变(OR1.72,95%CI1.30 至 2.28)、严重胃黏膜萎缩(OR2.77,95%CI1.22 至 6.29)、胃体肠上皮化生(OR3.15,95%CI1.67 至 5.96)、持续感染(OR2.08,95%CI1.60 至 2.72)和较低的胃蛋白酶原 I/II 比值(平均差异-0.54,95%CI-0.86 至-0.22)与 ER 后 MGL 显著相关。索引病变特征与 MGL 无显著相关性。914 例 MGL 中有 83.2%(95%CI72.2%至 91.9%)可进行 ER 治疗。

结论

ER 和胃次全切除术后的随访方案应不同,并根据不同的危险因素进一步个体化。

相似文献

1
Risk factors for gastric metachronous lesions after endoscopic or surgical resection: a systematic review and meta-analysis.内镜或手术切除后胃继发病变的危险因素:系统评价和荟萃分析。
Endoscopy. 2022 Sep;54(9):892-901. doi: 10.1055/a-1724-7378. Epub 2022 Feb 1.
2
Metachronous lesions after gastric endoscopic submucosal dissection: first assessment of the FAMISH prediction score.胃内镜黏膜下剥离术后的异时性病变:FAMISH 预测评分的首次评估。
Endoscopy. 2023 Oct;55(10):909-917. doi: 10.1055/a-2089-6849. Epub 2023 May 9.
3
Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan.内镜切除及幽门螺杆菌成功根除术后异时性胃癌的发病率及危险因素:日本一项大规模多中心队列研究的结果
Gastric Cancer. 2016 Jul;19(3):911-8. doi: 10.1007/s10120-015-0544-6. Epub 2015 Sep 29.
4
Risk factors for synchronous or metachronous tumor development after endoscopic resection of gastric neoplasms.胃肿瘤内镜切除术后同步或异时性肿瘤发生的危险因素。
Gastric Cancer. 2015 Oct;18(4):817-23. doi: 10.1007/s10120-014-0438-z. Epub 2014 Oct 18.
5
Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.幽门螺杆菌感染和胃蛋白酶原血清水平与内镜切除术后异时性胃肿瘤的风险相关。
Aliment Pharmacol Ther. 2017 Oct;46(8):758-767. doi: 10.1111/apt.14263. Epub 2017 Aug 11.
6
Helicobacter pylori Eradication on the Prevention of Metachronous Lesions after Endoscopic Resection of Gastric Neoplasm: A Meta-Analysis.幽门螺杆菌根除对胃肿瘤内镜切除术后异时性病变的预防作用:一项Meta分析
PLoS One. 2015 Apr 27;10(4):e0124725. doi: 10.1371/journal.pone.0124725. eCollection 2015.
7
The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer.早期胃癌内镜切除术后幽门螺杆菌状态与异时性胃癌发生率之间的关联。
Helicobacter. 2014 Jun;19(3):194-201. doi: 10.1111/hel.12116. Epub 2014 Mar 10.
8
Long-term natural history after endoscopic resection for gastric dysplasia.内镜切除治疗胃发育不良的长期自然病程。
Surg Endosc. 2021 Sep;35(9):5247-5255. doi: 10.1007/s00464-020-08023-3. Epub 2020 Sep 28.
9
Does Helicobacter pylori Eradication Reduce the Incidence of Metachronous Gastric Cancer After Curative Endoscopic Resection of Early Gastric Cancer: A Systematic Review and Meta-Analysis.根除幽门螺杆菌能否降低早期胃癌内镜根治性切除术后异时性胃癌的发生率:一项系统评价和荟萃分析
J Clin Gastroenterol. 2020 Mar;54(3):235-241. doi: 10.1097/MCG.0000000000001195.
10
Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer.早期胃癌内镜切除后,幽门螺杆菌根除对异时性胃癌发展的长期影响。
Gastrointest Endosc. 2012 Jan;75(1):39-46. doi: 10.1016/j.gie.2011.08.030. Epub 2011 Oct 21.

引用本文的文献

1
Helicobacter pylori Infection and Metachronous Gastric Cancer in Elderly Patients With Gastric Cancer Aged ≥ 75 Years Who Underwent Endoscopic Submucosal Dissection.年龄≥75岁的老年胃癌患者接受内镜黏膜下剥离术后幽门螺杆菌感染与异时性胃癌
Helicobacter. 2025 Jul-Aug;30(4):e70068. doi: 10.1111/hel.70068.
2
Therapeutic Potential of Qilianxiaopi Formula: Targeting ADAM17-Mediated Chronic Inflammation in Atrophic Gastritis.芪连消痞方的治疗潜力:针对萎缩性胃炎中ADAM17介导的慢性炎症
Pharmaceuticals (Basel). 2025 Mar 19;18(3):435. doi: 10.3390/ph18030435.
3
Comorbidities related to metachronous recurrence for early gastric cancer in elderly patients.
老年早期胃癌异时性复发相关的合并症
World J Gastrointest Endosc. 2025 Mar 16;17(3):99540. doi: 10.4253/wjge.v17.i3.99540.
4
A novel nomogram for predicting the morbidity of chronic atrophic gastritis based on serum CXCL5 levels.一种基于血清CXCL5水平预测慢性萎缩性胃炎发病率的新型列线图。
BMC Cancer. 2025 Jan 10;25(1):63. doi: 10.1186/s12885-024-13394-0.
5
eradication following endoscopic resection might prevent metachronous gastric cancer: a systematic review and meta-analysis of studies from Japan and Korea.内镜切除术后根除治疗可能预防异时性胃癌:一项对日本和韩国研究的系统评价与荟萃分析
Front Med (Lausanne). 2024 Sep 2;11:1393498. doi: 10.3389/fmed.2024.1393498. eCollection 2024.
6
MIR124-3 and NKX6-1 hypermethylation profiles accurately predict metachronous gastric lesions in a Caucasian population.MIR124-3 和 NKX6-1 高甲基化谱可准确预测高加索人群的胃同步性病变。
Clin Epigenetics. 2024 Aug 21;16(1):113. doi: 10.1186/s13148-024-01712-z.
7
Optimal Surveillance of Metachronous Gastric Lesion after Endoscopic Resection of Early Gastric Cancer.早期胃癌内镜切除术后胃黏膜病变的最佳监测。
Gut Liver. 2024 Sep 15;18(5):781-788. doi: 10.5009/gnl240027. Epub 2024 Aug 8.
8
Gastric microbiome signature for predicting metachronous recurrence after endoscopic resection of gastric neoplasm.胃肿瘤内镜切除术后预测异时复发的胃微生物组特征。
Gastric Cancer. 2024 Sep;27(5):1031-1045. doi: 10.1007/s10120-024-01532-3. Epub 2024 Jul 6.
9
Risk Assessment of Metachronous Gastric Neoplasm after Endoscopic Resection for Early Gastric Cancer According to Age at Eradication.早期胃癌内镜切除后根据根除时年龄评估异时性胃癌风险。
Gut Liver. 2024 Nov 15;18(6):992-1001. doi: 10.5009/gnl230383. Epub 2024 Mar 21.
10
Incidence and risk of remnant gastric cancer after gastrectomy for gastric cancer: a population-based study from the SEER database.胃癌胃切除术后残胃癌的发病率和风险:来自 SEER 数据库的基于人群的研究。
BMC Gastroenterol. 2024 Jan 16;24(1):35. doi: 10.1186/s12876-024-03133-x.